fermiscan starts selling!! .....

finally things are moving ...
Fermiscan is pleased to announce the commencement of a pre-commercialisation pilot for the
Fermiscan Breast Cancer Test in Australia.
The pilot program is aimed at gathering information on the use of the test in the clinical setting of
General Practice The Fermiscan Test will be used as an adjunct to clinical breast examination for
patients where there is a defined medical need for this type of screening.
The pilot will be conducted with '20' General Practitioner GROUPS in Sydney as a commercial service
in which patients will be charged $200 for the test.

No more free lollies! looks like there is a new vibe in the company, one that wants to move forward!
I think we have done enough sampeling en won awards, time to get it out there, get it sold, and together with 'sydneys breast clinic'(1.2 million/quarter), generating some positive cashflow or at least minimise the outflow.

Dj